InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,164.40
(
1.80%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.64
(
0.12%
)
Bitcoin
58,812.38
(
0.99%
)
Post# of 251689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4648
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: vinmantoo post# 251504

Thursday, 04/18/2024 5:09:37 PM

Thursday, April 18, 2024 5:09:37 PM

Post# of 251689

Right, EOLS is using an different and easier metric to fool uninformed people. Thanks for pointing that out.



Agree that in the published paper EOLS is reverting to the (bad) norm of plotting the time to reversion to baseline for *only* those patients who have previous responded to the neuromod. (Ie The KM curves start at 100%). This makes the graphs non comparable to Daxxy - and thus was stupid as a mechanism to compare to Daxxy (which is a more honest ITT).

That said, this appears to be the same data as in below link, and in that data, in an Apple to Apple comparison EOLS looks arguably as good as Daxxy..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173182528
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up